Detalhe da pesquisa
1.
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial.
Clin Infect Dis
; 73(1): 33-42, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33336698
2.
Once-daily Doravirine in Human Immunodeficiency Virus Type 1-Infected, Antiretroviral-naive Adults: An Integrated Efficacy Analysis.
Clin Infect Dis
; 70(7): 1344-1352, 2020 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31121015
3.
Once-daily Doravirine for Initial Treatment of Adults Living With Human Immunodeficiency Virus-1: An Integrated Safety Analysis.
Clin Infect Dis
; 70(7): 1336-1343, 2020 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31121013
4.
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.
Clin Infect Dis
; 68(4): 535-544, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30184165
5.
Host-gut microbiota derived secondary metabolite mediated regulation of Wnt/ß-catenin pathway: a potential therapeutic axis in IBD and CRC.
Front Oncol
; 14: 1392565, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38706602
6.
Molnupiravir: Mechanism of action, clinical, and translational science.
Clin Transl Sci
; 17(2): e13732, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593352
7.
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.
Lancet HIV
; 11(2): e75-e85, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141637
8.
Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine.
AIDS
; 35(5): 759-767, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587439
9.
Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development.
J Acquir Immune Defic Syndr
; 85(5): 635-642, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32925358
10.
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial.
Lancet HIV
; 7(1): e16-e26, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740348
11.
Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial.
J Acquir Immune Defic Syndr
; 81(4): 463-472, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30985556
12.
Doravirine dose selection and 96-week safety and efficacy versus efavirenz in antiretroviral therapy-naive adults with HIV-1 infection in a Phase IIb trial.
Antivir Ther
; 24(6): 425-435, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31355775
13.
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial.
Lancet HIV
; 5(5): e211-e220, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29592840
14.
Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study.
J Clin Endocrinol Metab
; 92(6): 2074-9, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17374706
15.
An initial pharmacokinetic study with a Metered Dose Transdermal Systemfor delivery of the progestogen Nestorone as a possible future contraceptive.
Contraception
; 76(6): 432-8, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18061700
16.
Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception.
Contraception
; 75(6): 454-60, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17519152
17.
Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations.
J Acquir Immune Defic Syndr
; 82(4): e47-e49, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31425317
18.
Detection of HIV-1 CXCR4 tropism and resistance in treatment experienced subjects receiving CCR5 antagonist-Vicriviroc.
J Clin Virol
; 55(2): 134-9, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22824230
19.
Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women.
Contraception
; 85(5): 480-8, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22176795
20.
Progesterone induces calcitonin expression in the baboon endometrium within the window of uterine receptivity.
Biol Reprod
; 68(4): 1318-23, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12606445